KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Progyny (PGNY) Equity Average (2019 - 2025)

Historic Equity Average for Progyny (PGNY) over the last 7 years, with Q3 2025 value amounting to $537.5 million.

  • Progyny's Equity Average rose 2064.45% to $537.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $537.5 million, marking a year-over-year increase of 2064.45%. This contributed to the annual value of $487.7 million for FY2024, which is 484.67% up from last year.
  • As of Q3 2025, Progyny's Equity Average stood at $537.5 million, which was up 2064.45% from $491.1 million recorded in Q2 2025.
  • In the past 5 years, Progyny's Equity Average ranged from a high of $562.5 million in Q1 2024 and a low of $175.8 million during Q1 2021
  • Its 5-year average for Equity Average is $388.0 million, with a median of $428.5 million in 2024.
  • Per our database at Business Quant, Progyny's Equity Average skyrocketed by 7366.58% in 2021 and then plummeted by 2096.05% in 2025.
  • Quarter analysis of 5 years shows Progyny's Equity Average stood at $238.0 million in 2021, then skyrocketed by 52.08% to $361.9 million in 2022, then soared by 47.66% to $534.4 million in 2023, then dropped by 19.82% to $428.5 million in 2024, then grew by 25.45% to $537.5 million in 2025.
  • Its Equity Average was $537.5 million in Q3 2025, compared to $491.1 million in Q2 2025 and $444.6 million in Q1 2025.